AMitchle MD PhD

Mannkind: Overlooked Biotech With Excellent Prospects (Part V)

One of the most important and well-documented facts about the pharmacology of exenatide (Byetta) is that the drug restores first-phase insulin response. The author of this article flatly states that Byetta does NOT have this effect. Publishing an error of this magnitude calls into question the credibility of the entire piece.